Full-Time

Univ – Open Rank Faculty

ICCT-Cancer Immunotherapy

Posted on 2/21/2026

Medical University of South Carolina

Medical University of South Carolina

No salary listed

Charleston, SC, USA

In Person

Category
Biology & Biotech (2)
,
Required Skills
Cell Biology
Requirements
  • PhD, MD, or MD/PhD in immunology, cell biology, biomedical engineering, or a related field
  • Postdoctoral experience with a strong record of research productivity
  • Evidence of or potential for securing independent funding (e.g., NIH R01, foundation grants)
  • Senior applicants should demonstrate a sustained track record of high-impact research and leadership
Responsibilities
  • Develop and lead a robust independent research program in cellular therapy and immuno-oncology
  • Foster interdisciplinary collaboration across MUSC’s academic, clinical, and translational units
  • Obtain extramural funding to support research endeavors
  • Publish impactful research in peer-reviewed scientific journals
  • Participate in the training and mentorship of graduate students, postdoctoral fellows, and clinical residents
  • Contribute to the strategic growth of the ICCT’s translational and clinical research initiatives
Desired Qualifications
  • Cancer immunotherapy and immune modulation
  • Genetic engineering of immune cells (CAR-T, TCR, NK)
  • Tumor microenvironment and immune evasion
  • Translational immunology and clinical trials
  • Gene editing, synthetic biology, and cell therapy manufacturing
  • Start-Up and Support: The successful candidate will receive a competitive start-up package tailored to support the launch and growth of their research program. This includes dedicated laboratory space, access to state-of-the-art core facilities, and administrative support for grant development. MUSC and the ICCT are committed to fostering faculty development through mentorship, interdisciplinary collaboration, and clinical integration.
Medical University of South Carolina

Medical University of South Carolina

View

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

INACTIVE